Overview: Allergy Alternaria Tenuis TestIntroduction: The Allergy Alternaria Tenuis Test detects IgE antibodies to Alternaria tenuis mold, which may cause sneezing, coughing, or asthma in moldy environments. Following 2023 AAAAI guidelines, it uses an immunoassay for high sensitivity, aiding in confirming mold allergies. This test is critical for guiding avoidance strategies or immunotherapy, preventing allergic reactions, and improving outcomes in allergology.
Other Names: Allergy Alternaria Assay, Alternaria Tenuis IgE Test.
FDA Status: Laboratory-developed test (LDT) meeting allergology standards for diagnostic accuracy.
Historical Milestone: Mold allergy testing began in the 1970s with skin tests. Specific IgE immunoassays emerged in the 1980s, and by the 2000s, advanced assays improved specificity for mold allergens like Alternaria.
Purpose: Diagnoses Alternaria tenuis mold allergies, guides avoidance or immunotherapy, and monitors allergic responses in patients with respiratory or asthma symptoms.
Test Parameters: 1. Alternaria Tenuis IgE
Pretest Condition: No fasting required. Collect serum or saliva at any time, preferably during symptom onset or mold exposure. Report symptoms like sneezing, coughing, or asthma, and list medications like antihistamines.
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document respiratory symptoms, mold exposure history, or family history of allergies or asthma. Include current medications, especially antihistamines or corticosteroids.
Consent: Written consent required, explaining the tests purpose, diagnostic implications, and potential need for avoidance or immunotherapy.
Procedural Considerations: Employs an immunoassay to measure Alternaria-specific IgE. Results are available in 1-2 days, supporting rapid diagnosis.
Factors Affecting Result Accuracy: Antihistamines or corticosteroids may suppress IgE levels, causing false negatives. Hemolysis or improper storage can degrade samples. Testing during low mold exposure may reduce sensitivity.
Clinical Significance: Elevated Alternaria-specific IgE confirms mold allergy, prompting avoidance or immunotherapy. Normal levels may require skin testing for confirmation.
Specialist Consultation: Consult an allergist for result interpretation. Pulmonology referral is advised for asthma-related cases.
Additional Supporting Tests: Skin prick test, total IgE, or mold allergy panel to confirm Alternaria allergy or identify cross-reactive molds.
Test Limitations: False negatives may occur with antihistamine use or low mold exposure. Cross-reactivity with other molds requires clinical correlation.
References: AAAAI Allergy Guidelines, 2023; Clinical and Translational Allergy, Denning DW, 2022.
